Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry
NCT ID: NCT05332782
Last Updated: 2022-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2022-03-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation
NCT05090540
The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair
NCT07045753
Prediction of Reverse Remodeling and Outcome in Patients With Severe Secondary Mitral Valve Regurgitation Undergoing Transcatheter Edge-to-edge Mitral Valve Repair
NCT04913727
Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair
NCT04200378
Outcome Registry and Assessment of New Edge-to-Edge Repair
NCT07108907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
M-TEER
Patients with primary mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient underwent M-TEER
* echocardiography data at baseline, procedure and follow-up
* follow-up of at least 12 months
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Kalbacher, MD
Role: PRINCIPAL_INVESTIGATOR
University Heart & Vascular Center Hamburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical Center
New York, New York, United States
Centre Hospitalier de Bordeaux
Bordeaux, , France
Université Lille, Inserm, Centre Hospitalier Universitaire de Lille
Lille, , France
University Hospital of Rennes, Centre Hospitalier de Rennes
Rennes, , France
University Heart & Vascular Center Hamburg
Hamburg, , Germany
Klinikum der Universität München
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Azeem Latib, MD
Role: primary
Andrea Scotti, MD
Role: backup
Thomas Modine, MD, PhD
Role: primary
Augustin Coisne, MD
Role: primary
Erwan Donal, MD
Role: primary
Sebastian Ludwig, MD
Role: backup
Jörg Hausleiter, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRIME-MR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.